Brief Co-Administration of Idelalisib May Improve the Long-Term Efficacy of Frontline Chemoimmunotherapy in Chronic Lymphocytic Leukaemia: 3-Year Follow-Up From the Rialto Trial

Hematological Oncology - United Kingdom
doi 10.1002/hon.32_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia

ISRN Oncology
2014English

Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2016English

Acalabrutinib With Obinutuzumab in Treatment-Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia: 3-Year Follow-Up

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Long-Term Follow-Up of Lower Dose Dasatinib (50 Mg Daily) as Frontline Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Cancer
Cancer ResearchOncology
2019English

Five‐year Survival Follow‐up of a Phase III Randomised Trial Comparing Ofatumumab Versus Physicians' Choice for Bulky Fludarabine‐refractory Chronic Lymphocytic Leukaemia: A Short Report

British Journal of Haematology
Hematology
2020English

Chondrodysplasia Punctata - Long Term Follow Up of 3 Cases.

Orthopedics & Traumatology
1984English

Long-Term Assessment of Didanosine, Lamivudine, and Efavirenz in Antiretroviral-Naive Patients: 3-Year Follow-Up

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2008English

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy